Skip to main content
mSphere logoLink to mSphere
. 2019 Jun 26;4(3):e00440-19. doi: 10.1128/mSphere.00440-19

Erratum for Ramakrishnan et al., “Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21”

Amritha Ramakrishnan a,*, Nina M Schumack b,c, Christina L Gariepy b,c, Heather Eggleston b,c, Gladys Nunez a, Nereyda Espinoza a, Monica Nieto a, Rosa Castillo a, Jesus Rojas a, Andrea J McCoy a, Zoltan Beck d, Gary R Matyas e, Carl R Alving e, Patricia Guerry c, Frédéric Poly c, Renee M Laird b,c,
PMCID: PMC6595154  PMID: 31243083

ERRATUM

Volume 4, issue 3, e00101-19, 2019, https://doi.org/10.1128/mSphere.00101-19. In Table 1, the third value in the CPS-CRM + ALFQ row should be 86, not 8. The corrected table appears here.

TABLE 1.

Protective efficacy of the CPS-CRM vaccine in A. nancymaae NHPs using various adjuvants

Group No. of
animals
Diarrhea attack
rate, n (%)
Protective efficacy
against diarrhea (%)a
Pb
CPS-CRM + alum 10 5 (50) 29 0.43
CPS-CRM + ALF 17 4 (24) 66 0.008
CPS-CRM + ALFQ 10 1 (10) 86 0.005
PBS 20 14 (70)
a

Protective efficacy was calculated as follows: [(attack rate of PBS-treated animals − attack rate of vaccinated animals)/attack rate of PBS-treated animals] × 100.

b

Determined using a Fisher exact test with no adjustment for multiple comparisons.


Articles from mSphere are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES